SARS-CoV-2 spike protein-associated sialoglycoconjugates induce nanoscale filipodia to facilitate micro-size platelet clotting
COVID-19 disease is associated with thrombosis, but the pathogenic mechanism remains unclear. Here, we investigate how SARS-CoV-2 spike protein causes platelet...
Global estimates of vaccine-associated narcolepsy from 1967 to 2023
Regional evidence on the signal detection between narcolepsy and vaccines is scarcely available and insufficiently understood, thus impeding a comprehensive understanding of this relationship on a global scale. Therefore, this...
Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination
Messenger RNA (mRNA) vaccines against SARS-CoV-2 are highly effective and were instrumental in curbing the COVID-19 pandemic. However, rare cases of noninfective myocarditis...
Article in The Atlantic (paywall):
Do Childhood Vaccines Cause Tornadoes? It hasn’t been ruled out.
Link to same article on MSN (no paywall):
https://www.msn.com/en-us/science/general/do-childhood-vaccines-cause-tornadoes/ar-AA1QV10w
Abstract
Injected COVID-19 vaccines protect against severe disease, but do not induce robust mucosal immune responses. Nasal vaccines offer the advantage of local immunity to block viral infection and transmission. Previously we showed immunization of a Pam2Cys-adjuvanted SARS-CoV-2 vaccine to...
[Posted on behalf of @MSEsperanza]
https://brieflands.com/articles/jamm-12285.html
Background:
The medical community fails dramatically in the understanding of chronic diseases and development of causal therapies. Statistical associations between vaccinations or infections and autoimmune...
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients
Authors: Takehiro Nakahara et al
Published Online: Sep 19 2023
Abstract
Background
Patients who developed myocarditis after SARS-CoV-2 vaccination show abnormalities on cardiac...
I’ve heard a few stories about the impact of HPV vaccination on cervical cancer rates in the UK and elsewhere recently but this has some of the best graphs and charts to visualise it all worldwide
https://ourworldindata.org/hpv-vaccination-world-can-eliminate-cervical-cancer
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic
Abstract
Background
During the COVID‐19 pandemic focus has been on polyethylene glycol (PEG) and polysorbate as these excipients are...
SARS-CoV-2 Spike Protein Downregulates Cell Surface α7nAChR through a Helical Motif in the Spike Neck
Tommy S. Tillman; Qiang Chen; Vasyl Bondarenko; Jonathan A. Coleman; Yan Xu; Pei Tang
A deficiency of the functional α7 nicotinic acetylcholine receptor (α7nAChR) impairs neuronal and immune...
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Lee, Yeji; Jeong, Michaela; Park, Jeongeun; Jung, Hyein; Lee, Hyukjin
Several studies have utilized a lipid nanoparticle delivery system to enhance the effectiveness of mRNA therapeutics and...
Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study
Lisa Lundberg-Morris; Susannah Leach; Yiyi Xu; Jari Martikainen; Ailiana Santosa; Magnus Gisslén; Huiqi Li; Fredrik Nyberg; Maria Bygdell
Objectives
To investigate...
Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis
Lael M. Yonker; Zoe Swank; Yannic C. Bartsch; Madeleine D. Burns; Abigail Kane; Brittany P. Boribong; Jameson P. Davis; Maggie Loiselle; Tanya Novak; Yasmeen Senussi; Chi-An Cheng; Eleanor Burgess; Andrea G. Edlow...
Murine Alveolar Macrophages Rapidly Accumulate Intranasally Administered SARS-CoV-2 Spike Protein leading to Neutrophil Recruitment and Damage
Chung Park, Il-Young Hwang, Serena Li-Sue Yan, Sinmanus Vimonpatranon, Danlan Wei, Don Van Ryk, Claudia Cicala, James Arthos, John H Kehrl
(National...
GSK’s older adult respiratory syncytial virus (RSV) vaccine candidate shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
Data to be presented at IDWeek 2022 showed overall vaccine efficacy against RSV-lower respiratory tract disease (LRTD) in...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.